개요
The Extended GH Stack adds IGF-1 LR3 to the classic CJC-1295 + Ipamorelin base, creating a three-tier growth hormone axis protocol that addresses GH secretion, GH release, and downstream IGF-1 signaling simultaneously. CJC-1295 and Ipamorelin handle the upstream signaling — increasing GH output through GHRH and ghrelin pathways respectively. IGF-1 LR3 (a long-acting analog of Insulin-like Growth Factor-1) enters downstream, acting directly on muscle, bone, and organ cells to drive protein synthesis, cellular hypertrophy, and tissue growth — the actual anabolic outcomes that elevated GH is designed to produce. The practical advantage of adding IGF-1 LR3 is ensuring the anabolic signal reaches peripheral tissue even when natural liver conversion of GH to IGF-1 is suboptimal — common with age, metabolic dysfunction, or intensive training loads. IGF-1 LR3 has a 20–30 hour half-life compared to native IGF-1''s minutes, providing sustained receptor activation throughout the day. This stack is for experienced users who have established a response to the classic GH stack and want to extend its downstream effects. IGF-1 LR3 is administered post-workout to direct its anabolic action toward recently trained muscle tissue. This protocol requires blood work monitoring of IGF-1 levels (often quarterly), fasting glucose, and HbA1c due to IGF-1''s insulin-like effects on glucose metabolism.
용량 프로토콜
300 mcg
1회 용량당
300 mcg
1회 용량당
50 mcg
1회 용량당
목표 및 증거
경고
- IGF-1 LR3 carries significant risk if IGF-1 levels are not monitored. Contraindicated with any cancer history. Requires medical supervision.
Comments
Sign in to join the discussion
주의: 이 스택은 커뮤니티에서 제출된 것이며 연구용으로만 사용됩니다. Peptide Contacts는 제출된 스택의 안전성이나 효능을 검증하지 않습니다. 펩타이드 프로토콜을 사용하기 전에 항상 자격이 있는 의료 전문가와 상의하세요.